Recovery from neurological injuries is typically incomplete and often results in significant
and permanent disabilities. Currently, most available therapies are limited to supportive or
palliative measures, aimed at managing the symptoms of the condition. Because restorative
therapies targeting the underlying cause of most neurological diseases do not exist, cell
therapies targeting anti-inflammatory, neuroprotective and regenerative potential hold great
promise. Cord blood (CB) cells can induce repair through mechanisms that involve trophic …